A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once. Traditionally, vaccines protect against one ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range ...

A vaccine usually trains your immune system to recognize one target. Here, the target is basically “anything that doesn’t ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

The MarketWatch News Department was not involved in the creation of this content. A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data ...

A Stanford University School of Medicine research team has developed a vaccine technology that can prevent respiratory ...

Researchers have invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens – the closest yet ...

TLR4 agonists can drive potent antitumor immunity, but their clinical use has been constrained by systemic toxicities. We ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Population bottlenecks caused by stark population loss due to illness or habitat destruction caused mammals' disease immunity to decline, according to a new study led by computational biologists in ...

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research ...